mafosfamide has been researched along with Disease Models, Animal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Reich, S; Sidi, H; Slavin, G; Slavin, S; Weiss, L | 1 |
| Nusair, S; Reich, S; Sidi, H; Slavin, S; Weiss, L | 1 |
| de Groot, CJ; Hagenbeek, A; Martens, AC | 1 |
3 other study(ies) available for mafosfamide and Disease Models, Animal
| Article | Year |
|---|---|
Successful purging of murine plasmacytoma by mafosfamide (ASTA-Z).
Topics: Animals; Antineoplastic Agents; Bone Marrow Purging; Cyclophosphamide; Disease Models, Animal; Humans; Mice; Mice, Inbred BALB C; Multiple Myeloma; Plasmacytoma; Transplantation, Autologous | 1994 |
Induction of graft versus leukemia effects by cell-mediated lymphokine-activated immunotherapy after syngeneic bone marrow transplantation in murine B cell leukemia.
Topics: Adjuvants, Immunologic; Animals; Bone Marrow; Bone Marrow Cells; Bone Marrow Purging; Bone Marrow Transplantation; Cyclophosphamide; Disease Models, Animal; Graft vs Host Disease; Immunotherapy, Adoptive; Interleukin-2; Leukemia, B-Cell; Lymph Nodes; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Spleen; T-Lymphocytes | 1996 |
Development and characterisation of a cyclophosphamide resistant variant of the BNML rat model for acute myelocytic leukaemia.
Topics: Animals; Antineoplastic Agents; Cell Line; Cyclophosphamide; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance; Ifosfamide; Leukemia, Myeloid, Acute; Male; Neoplastic Stem Cells; Rats; Rats, Inbred BN | 1991 |